Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Device Makers Unite To Develop Heart Pump In U.S.

This article was originally published in PharmAsia News

Executive Summary

Japanese medical device makers Asahi Kasei and Misuzu & Sun Medical Holdings have entered into an agreement to develop and market Misuzu's implantable heart-assist device in the United States and elsewhere. Under the agreement, Asahi Kasei bought a 60 percent stake in Misuzu's U.S. subsidiary, Evaheart Medical USA for $7.5 million and is to cover the cost of clinical trials in the United States. The device under development is Misuzu's left ventricular assist system that helps the heart circulate blood via an implantable pump. The firm already has applied for approval in Japanese. (Click here for more - a subscription may be required)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts